Decision on Stock Split and Share Count Correction


  • Decision on 5:1 reverse stock split (par value from KRW 100 to KRW 500)
  • Total shares after split: 5,577,410 (corrected from 5,575,074)
  • 2,336 fractional shares to be merged into treasury
  • Purpose: stabilize stock price and enhance corporate value through appropriate share count
  • Schedule: shareholder meeting 2026-03-31, effective 2026-04-16, trading suspension 2026-04-14~05-14, listing 2026-05-15
  • No capital reduction; subject to shareholder approval
ADVERTISEMENT (250px+)

KOSDAQ Filing Information


  • Filing: [Correction of Description] Decision on Stock Consolidation
  • Company: KMPHARMACEUTICAL (225430)
  • Submission: KMPHARMACEUTICAL Co.,Ltd.
  • Receipt: 05-07-2026
  • Under KRX KOSDAQ Market Division